The differential diagnosis of parkinsonian syndromes is considered one of the most
challenging in neurology and error rates in the clinical diagnosis can be high even at …

ABSTRACT PSP is a pathologically defined neurodegenerative tauopathy with a variety of
clinical presentations including typical Richardson's syndrome and other variant PSP …

Background Clinical differentiation of parkinsonian syndromes is still challenging. Objectives
A fully automated method for quantitative MRI analysis using atlas‐based volumetry …

Introduction Differentiating clinically progressive supranuclear palsy-parkinsonism (PSP-P)
from Parkinson's disease (PD) may be challenging, especially in the absence of vertical …

Magnetic resonance imaging (MRI)‐based brain volumetry is increasingly being used in the
clinical setting to assess brain volume changes from structural MR images in a range of …

Background Differentiating progressive supranuclear palsy‐parkinsonism (PSP‐P) from
Parkinson's disease (PD) is clinically challenging. Objective This study aimed to develop an …

Background Progressive supranuclear palsy (PSP) is a clinically heterogenous atypical
parkinsonian syndrome. Therefore, early recognition and correct diagnosis of PSP is …

Background Magnetic resonance brainstem measurements are useful structural biomarkers
in the Richardson's syndrome variant of progressive supranuclear palsy (PSP). However, it …

Abstract Background The Magnetic Resonance Parkinsonism Index is listed as one of the
most reliable imaging morphometric markers for diagnosis of progressive supranuclear …

Objectives This study aims at a fully automatic pipeline for measuring the magnetic
resonance parkinsonism index (MRPI) using deep learning methods. Methods MRPI is …